Europe’s Growing Problem with ‘Zombie’ Fund Managers
Across Europe’s private equity and venture capital landscape, a quiet crisis is unfolding. A rising number of long-dated, underperforming funds are being run by so‑called zombie fund GPs – general partners who still collect management fees but have little realistic prospect of generating meaningful returns or raising a new fund.
These vehicles, often launched in the boom years of easy money, now sit in a kind of professional limbo. Their portfolio companies are mature, exits are scarce, and limited partners (LPs) are increasingly frustrated by capital locked in structures that no longer match their risk–return expectations.
How Funds Become ‘Zombies’
A fund typically drifts into zombie status when it reaches or passes its contractual term without delivering sufficient distributions or convincing performance. The GPs continue to draw management fees, but they struggle to attract fresh commitments. Without new capital, teams shrink, deal flow dries up and incentives skew towards preserving fee streams rather than aggressively pursuing exits or write‑downs.
Regulatory constraints, higher interest rates and a frozen IPO market in Europe have amplified the problem. Exit routes via trade sales or secondary buyouts are harder to execute, leaving managers with ageing portfolios and limited strategic options.
Impact on LPs, Founders and the Market
For institutional investors – from pension funds to family offices – zombie funds tie up capital that could be redeployed into higher‑performing strategies. The result is a drag on overall portfolio returns and a growing focus on secondary transactions to offload stale positions at a discount.
Founders backed by these funds face their own challenges. With GPs in survival mode, follow‑on financing, operational support and board engagement can all weaken. That, in turn, depresses company valuations and makes future fundraising rounds more complex.
Emerging Solutions and the Road Ahead
Specialist secondary funds and GP‑led restructurings are emerging as key tools to clean up the long tail of legacy portfolios. Transactions such as continuation vehicles, tender offers and strip sales allow LPs to gain liquidity while giving stronger assets more time under refreshed incentive structures.
At the same time, sophisticated LPs are tightening due diligence on fund governance, key‑person provisions and sunset clauses to reduce the risk of future zombie situations. For Europe’s venture ecosystem to remain competitive, market participants argue that transparency, active portfolio management and realistic valuation policies must become non‑negotiable standards.
As the era of cheap capital recedes, the fate of Europe’s zombie fund GPs will serve as a stress test for how resilient – and how disciplined – the continent’s private markets have truly become.